Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in Ireland and UK or involving organisations from these countries.

Total search results: 2841 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Biocon–Evotec: biosimilars, 201910– license €na to Biocon Biologics for pre-clinical biosimilar asset of Just-Evotec Biologics 2019-10-10
D.I. Biotech–Solentim: laboratory equipment, 201910 distribution existent of Solentim’s cell line developm instruments in Korea by D.I. Biotech Ltd 2019-10-09
Imperial Life Sciences–Solentim: laboratory equipment, 201910 distribution existent of Solentim’s cell line developm instruments in India by Imperial 2019-10-09
Kiko Tech–Solentim: laboratory equipment, 201910 distribution existent of Solentim’s cell line developm instruments in Japan by Kiko Tech Co Ltd 2019-10-09
N-Side–Sciad Communications: public relations, 201910 service existent by Sciad 2019-10-09
Optec (RU)–Solentim: laboratory equipment, 201910 distribution existent of Solentim’s cell line developm instruments in Russia by Optec LLC 2019-10-09
Trio Biotech–Solentim: laboratory equipment, 201910 distribution existent of Solentim’s cell line developm instruments in China by Trio Biotech Co Ltd 2019-10-09
Unimed Healthcare–Solentim: laboratory equipment, 201910 distribution existent of Solentim’s cell line developm instruments in Taiwan by Unimed 2019-10-09
GSK–Lyell Immunopharma: cancer cell therapy, 201910–202409 collab 5y developm of technologies to improve cancer cell therapies 2019-10-08
MiroBio–Advent Venture Partners: investment, 201910 financing round Series A totalling £27m incl co-investor Advent Life Sciences 2019-10-07
MiroBio–GSK: investment, 201910 financing round Series A totalling £27m incl co-investor SR One 2019-10-07
MiroBio–Samsara Biocapital: investment, 201910 financing round Series A totalling £27m incl co-lead investor Samsara Biocapital 2019-10-07
MiroBio–SEVERAL: investment, 201910 financing round Series A £27m co-led by Oxford Sciences Innovation + Samsara Biocapital 2019-10-07
MiroBio–Univ Oxford: investment, 201910 financing round Series A totalling £27m incl co-lead investor Oxford Sciences Innovation 2019-10-07
Congenica–Genomenon: genomic software tools, 201910– collab integration of Mastermind Genomic Search Engine into clinical decision support s/w 2019-10-02
AstraZeneca–N-Side: clinical supply chain management s/w, 201910– supply implementation of cloud-based N-Side Suite for Clincial Trials 2019-10-01
Novartis–Microsoft: artificial intelligence, 201910– collab strategic multiyear AI for drug r+d + commercialisation 2019-10-01
Arctoris–SEVERAL: investment, 201909 seed financing round £3.2m led by RT Partners 2019-09-30
STipe Therapeutics–SEVERAL: investment, 201909 financing round Series A €20m co-led by Arix Bioscience + Novo Holdings 2019-09-30
MolPort–Alto Marketing: public relations, 201909 service existent by Alto Marketing Ltd 2019-09-24
Oncimmune–IPF Partners: credit, 201909– 202309 credit facility €8.5m four year incl warrant for 2m new ordinary shares IPF Management SA 2019-09-20
BenevolentAI–Temasek: investment, 201909 investment $90m from Tesmasek 2019-09-17
Life Healthcare Group–AC Immune: PET tracer, 201909 collab existent developm Tau PET tracer PI-2620 with Life Molecular Imaging 2019-09-17
Autolus–PPF Group: investment, 201909 acquisition 19.2% stake in market through Nasdaq by PPF Group NV 2019-09-16
Avalon Ventures–GSK: investment, 201909 acquisition of Sitari Pharmaceuticals incubated 11/13 as part of GSK/Avalon collaboration 2019-09-11
Cedilla Therpapeutics–o2h: drug discovery services, 201909– collab expansion synthetic chemistry services for small molecules for protein regulation 2019-09-11
4BIO Ventures–SEVERAL: investment, 201909 first closing $50m of 4BIO Ventures II fund targeting $150m 2019-09-09
BioNTech–SEVERAL: investment, 201909–201910 US IPO $150m+$22.5m with 10m+1.5mADSs at $15/ADS at Nasdaq Global Select Market 2019-09-09
Lightcast Discovery–Instinctif Partners: public relations, 201909 service existent by Instinctif 2019-09-09
Lightcast Discovery–SEVERAL: investment, 201909 seed financing round £1.3m ($1.6m) from private investors 2019-09-09
iStar Medical–Optimum Strategic Communications: public relations, 201909 service existent by Optimum 2019-09-05
Theragnostics–AstraZeneca: PARP inhibitors, 201909– license ww freedom to operate for developm of rPARPi as cancer theragnostic 2019-09-05
Theragnostics–Optimum Strategic Communications: public relations, 201909 service existent by Optimum 2019-09-05
Achilles Therapeutics–Forbion: investment, 201909 financing round Series B totalling £100m incl new + co-investor Forbion 2019-09-03
Achilles Therapeutics–Invus Group: investment, 201909 financing round Series B totalling £100m incl new + co-investor Invus 2019-09-03
Achilles Therapeutics–Perceptive Advisors: investment, 201909 financing round Series B totalling £100m incl new + co-investor Perceptive Advisors 2019-09-03
Achilles Therapeutics–RA Capital Management: investment, 201909 financing round Series B totalling £100m incl new + lead investor RA Capital 2019-09-03
Achilles Therapeutics–Redmile Group: investment, 201909 financing round Series B totalling £100m incl new + co-investor Redmile Group 2019-09-03
Achilles Therapeutics–SEVERAL: investment, 201909 financing round Series B £100m led by RA Capital Management 2019-09-03
Achilles Therapeutics–Syncona: investment, 201909 financing round Series B totalling £100m incl existing + co-investor Syncona 2019-09-03
Univ College London–Bruker Corp: atomic force microscope, 201908 supply existent London Centre for Nanotechnology long-term user of NanoWizard systems 2019-09-02
Kinomica–BioCity (GB): investment, 201908 investment by BioCity via Innovate UK Precision Medicine Investment Accelerator 2019-08-29
Protelux (RU)–Unibio: protein production from methane, 201908 collab existing buidling + operating plant for Uniprotein production in Russia 2019-08-28
Unibio–SEVERAL: investment, 201908 financing round $15m (£12.4m) from existing + new shareholders led by West Hill Capital 2019-08-28
Unibio–West Hill Capital: investment, 201908 financing round totalling $15m (£12.4m) incl lead investor West Hill Capital 2019-08-28
Adaptimmune–Noile-Immune: T cell therapy, 201908– collab up to $312m + royalties developm of SPEAR T-cell products using PRIME technology 2019-08-27
Vaccitech–Scius Communications: public relations, 201908 supply service existent by Scius Communications 2019-08-27
AstraZeneca–FibroGen: roxadustat, 201908 collab existent commercialisation of roxadustat in China by AstraZeneca 2019-08-22
Juvenescence–SEVERAL: investment, 201908 financing round Series B $100m incl founders + private investment companies 2019-08-19
AstronauTx–United Kingdom (govt): investment, 201908 investment £6.5m from Dementia Discovery Fund 2019-08-13
Synpromics–AskBio: investment, 201908 acquisition of Synpromics Ltd by Asklepios Biopharmaceutical Inc 2019-08-13
Cavion–Jazz Pharmaceuticals: investment, 201908 acquisition $52.5m upfront + $260m milestones of Cavion Inc by Jazz 2019-08-12
MeiraGTx–SEVERAL: investment, 201908 public offering $75.2m+$11.28m with 3.2m+480k ordinary shares at $23.5/share 2019-08-07
Imcyse–Andrew Lloyd Associates: public relations, 201908 service existent by ALA 2019-08-05
Atlantic Healthcare–Consilium: public relations, 201907 service existent European IR + media relations by CSC 2019-07-31
Atlantic Healthcare–Lazar Partners: public relations, 201907 service existent US IR + media relations by Lazar Partners 2019-07-31
Wellington Partners–Consilium: public relations, 201907 service existent by CSC 2019-07-31
PredictImmune–BGF (GB): investment, 201907 financing round Series B totalling £10m incl new investor BGF 2019-07-30
PredictImmune–Cambridge Innovation Capital: investment, 201907 financing round Series B totalling £10m incl new investor CIC 2019-07-30
PredictImmune–Limewash: public relations, 201907 service existent by Limewash 2019-07-30
PredictImmune–Parkwalk Advisors: investment, 201907 financing round Series B totalling £10m incl existing investor Parkwalk Opportunities Fund 2019-07-30
PredictImmune–SEVERAL: investment, 201907 financing round Series B £10m incl Parkwalk + Cambridge Enterprise + BGF + Cambridge Innovation Capital 2019-07-30
PredictImmune–Univ Cambridge: investment, 201907 financing round Series B totalling £10m incl existing investor Cambridge Enterprise 2019-07-30
Quanta Dialysis Technologies–SEVERAL: investment, 201907 financing round Series C £38m led by Swiss family office + btov Partners 2019-07-29
Exscientia–Rallybio: orphan drug discovery, 201907– collab €na joint venture to discover small molecule drugs using Centaur Chemist platform 2019-07-23
Medicxi Ventures–JnJ: investment, 201907 closing totalling €400m of Medicxi III fund incl cornerstone investors + Novartis + JJDC 2019-07-19
Medicxi Ventures–Novartis: investment, 201907 closing totalling €400m of Medicxi III fund incl cornerstone investors + Novartis + JJDC 2019-07-19
Medicxi Ventures–SEVERAL: investment, 201907 closing €400m of Medicxi III fund incl cornerstone investors + Novartis + JJDC 2019-07-19
Mallinckrodt–Silence Therapeutics: RNAi drugs, 201907– collab developm + commercialisation $20m upfront + milestones + royalties plus $5m investment 2019-07-18
Silence Therapeutics–Mallinckrodt: investment, 201907 investment £4m with 5m new ordinary shares at 79p/share as part of collab = 6.5% share 2019-07-18
BPCE–Illumina: business services, 201907– collab Illumina Accelerator UK + Seventure Partners to provide funding + lab services + coaching to startups 2019-07-16
F-Prime–Illumina: business services, 201907– collab Illumina Accelerator UK + F-Prime Capital to provide funding + lab services + coaching to startups 2019-07-16
Roche–Sosei: GPCR-targeting drugs, 201907– collab multi-target research + licensing up to >$1b Genentech + Sosei Heptares 2019-07-16
Sofinnova–Illumina: business services, 201907– collab Illumina Accelerator UK to provide funding + lab services + coaching to startups 2019-07-16
SV Health Investors–Illumina: business services, 201907– collab Illumina Accelerator UK to provide funding + lab services + coaching to startups 2019-07-16
Recursion Pharmaceuticals–SEVERAL: investment, 201907 financing round Series C $121m led by Baillie Gifford 2019-07-15
Vasopharm–Optimum Strategic Communications: public relations, 201907 service existent by Optimum 2019-07-11
Nanoform–Notch Communications: public relations, 201907 service existent by Notch 2019-07-10
Start Codon–Zyme Communications: public relations, 201907 service existent by Zyme 2019-07-10
BioNTech–SEVERAL: investment, 201907 financing round Series B $325m led by Fidelity ./. €87.7m delayed as of 9/19 2019-07-09
Revolution Medicines–Schroders: investment, 201907 financing round Series C totalling $100m incl existing + co-investor Schroder Adveq 2019-07-09
Breakpoint Therapeutics–Evotec: investment, 201907 first financing round totalling €30m incl co-investor Evotec 2019-07-08
Breakpoint Therapeutics–Medicxi: Vemtures investment, 201907 first financing round totalling €30m incl lead investor Medicxi 2019-07-08
Breakpoint Therapeutics–Otsuka: investment, 201907 first financing round totalling €30m incl co-investor Taiho Ventures LLC 2019-07-08
Breakpoint Therapeutics–SEVERAL: investment, 201907 first financing round €30m for spin-out from Evotec led by Medicxi + incl Taiho Ventures + Evotec 2019-07-08
Ahren Innovation Capital–SEVERAL: investment, 201907 closing of first fund Ahren LP in excells of £200m 2019-07-01
Antimicrobials Working Group–Entasis Therapeutics: antibiotics, 201907– collab existent Entasis is member of AWG 2019-07-01
Antimicrobials Working Group–Iterum Therapeutics: antibiotics, 201907– collab existent Iterum is member of AWG 2019-07-01
ExpreS2ion Biotech–ERS Genomics: CRISPR technology, 201907– license non-excl €na for use + commercialisation of products from ERS Genomics 2019-07-01
Biodesix–Oncimmune: clinical proteomic cancer test, 201906– collab excl commercialisation of EarlyCDT Lung in US by Biodesix 2019-06-28
Sanifit–Consilium: public relations, 201906 service existent by CSC 2019-06-26
Sanifit–la Caixa: investment, 201906 financing round Series D totalling €55.2m incl existing + lead investor Caixa Capital Risc 2019-06-26
Sanifit–SEVERAL: investment, 201906 financing round Series D €55.2m led by Caixa Capital Risc 2019-06-26
Sanifit–SEVERAL: investment, 201906c capitalisation of €17m of convertible bonds 2019-06-26
Avacta–JSR Corp: cell line development, 201906– CHO cell line development for clinical manufacturing of AVA004 Affimer PD-L1 antagonist by Selexis 2019-06-20
Drax Group–Deep Branch Biotechnology: carbon recycling, 201906– collab research carbon dioxide of power generation for single cell protein production 2019-06-18
ADC Therapeutics–SEVERAL: investment, 201906–201907 financing round Series E expansion $103m bringing total Series E to $303m 2019-06-12
GT Apeiron–Exscientia: drug discovery, 201906– collab AI-based drug discovery using Centaur Chemist incl shares + milestones + royalties 2019-06-11
Binding Site–Tecan: laboratory automation, 201906 collab existent developm automated solution for using MALDI-MS to diagnose blood cancers 2019-06-06
Yukin Therapeutics–SEVERAL: investment, 201906 financing round €3.3m co-led by Advent France Biotechnology + Medicxi 2019-06-04
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29  next pagenext page



Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group BIO-Europe 2019 Hamburg Germany BEU2019 650x80px

» top